What is Manhattan Labs?
Manhattan Labs operates as a premier, service-oriented independent clinical laboratory, specifically catering to the complex needs of the New York City metropolitan area. The firm distinguishes itself by integrating advanced clinical laboratory technology with a highly personalized service framework, effectively bridging the gap between technical diagnostic precision and patient-centric accessibility. By focusing on exceptional turnaround times and seamless result delivery, the company has established itself as a critical node in the regional healthcare ecosystem, setting new benchmarks for quality and reliability in the laboratory industry.
How much funding has Manhattan Labs raised?
Manhattan Labs has raised a total of $4M across 2 funding rounds:
Other Financing Round
$3.7M
Debt
$350K
Other Financing Round (2013): $3.7M with participation from Trevi Health Ventures
Debt (2020): $350K led by PPP
Key Investors in Manhattan Labs
Trevi Health Ventures
A specialist investment firm providing healthcare-focused alternative asset management, with a deep emphasis on medical devices, biopharmaceuticals, and healthcare services.
PPP
Public-Private Partnership
What's next for Manhattan Labs?
With the recent infusion of capital, Manhattan Labs is poised to accelerate its operational expansion and technological integration. The strategic focus will likely center on enhancing laboratory throughput and digitizing result-access protocols to meet the evolving requirements of modern healthcare providers. As the firm navigates the complexities of the diagnostic market, the emphasis will remain on maintaining its reputation for excellence while scaling its service footprint. Future growth initiatives are expected to leverage this financial foundation to further optimize diagnostic workflows, ensuring that the company remains a preferred partner for clinical diagnostics in an increasingly data-driven medical environment.
See full Manhattan Labs company page
